Journal of Molecular Diagnostics

Aims & Scope

The Journal of Molecular Diagnostics, the official publication of the Association for Molecular Pathology (AMP), co-owned by the American Society for Investigative Pathology (ASIP), seeks to publish high quality original papers on scientific advances in the translation and validation of molecular discoveries in medicine into the clinical diagnostic setting, and the description and application of technological advances in the field of molecular diagnostic medicine.

The editors welcome for review articles that contain: novel discoveries or clinicopathologic correlations including studies in oncology, infectious diseases, inherited diseases, predisposition to disease, clinical informatics, or the description of polymorphisms linked to disease states or normal variations; the application of diagnostic methodologies in clinical trials; or the development of new or improved molecular methods which may be applied to diagnosis or monitoring of disease or disease predisposition.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.4
2024	3.40

Journal Rank

Year	Value
2024	3115

Journal Citation Indicator

Year	Value
2024	1141

SJR (SCImago Journal Rank)

Year	Value
2024	1.294

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	115

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• RNAscope

  Citation: 2323

  Authors: Fay, John, Nan, Li-Chong, Son, Allissa, Xingyong, Hong-Thuy, Xiao-Jun, Yuling

• Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)

  Citation: 1862

  Authors: Donavan T., Talia N., Ahmet, Ronak H., Ryma, Aijazuddin, Raghu, Zhen Yu, Helen H., Sasinya N., A. Rose, Catherine, Justyna, Jacklyn, Angela, Jaclyn F., Jinjuan, Wei, Dara S., Alifya, Snjezana, Laetitia, Meera, Khedoudja, Maria E., Marc, Michael F.

• Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer

  Citation: 1606

  Authors: Marilyn M., Michael, Eric J., Shashikant, Neal I., Somak, Apostolia M., Cindy L., Daynna J., Anas, Marina N.

• Analysis of Microarray Data Using Z Score Transformation

  Citation: 867

  Authors: Chris, Marquis P., William J., Kevin G.

• Guidelines for Validation of Next-Generation Sequencing–Based Oncology Panels

  Citation: 593

  Authors: Lawrence J., Maria E., Christopher, Suzanne, Ira M., John, Robyn L., Karl V., Marina N.

• Immunohistochemistry versus Microsatellite Instability Testing For Screening Colorectal Cancer Patients at Risk For Hereditary Nonpolyposis Colorectal Cancer Syndrome

  Citation: 520

  Authors: Jinru

• Sensitive Sequencing Method for KRAS Mutation Detection by Pyrosequencing

  Citation: 413

  Authors: Shuji, Takako, Mohan, Liying, Mami, Chungdak, Mari, Gregory Y., Massimo, Charles S.

• Comparison of Sanger Sequencing, Pyrosequencing, and Melting Curve Analysis for the Detection of KRAS Mutations

  Citation: 411

  Authors: Athanasios C., Alexis, Roy G., Michael J., Christopher D., James R., Kathleen M.

• Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines

  Citation: 397

  Authors: Somak, Christopher, Arivarasan, Nefize S., Eric W., Stephen E., Annette, Mrudula, Robyn L., Karl V., Chen, Alexis B.

• Molecular Classification and Correlates in Colorectal Cancer

  Citation: 365

  Authors: Shuji, Ajay

---